Brazil SUS expands access to 9 cancer drugs for 116,000 patients

Brazil's public health system (SUS) will now offer nine cancer medicines that were previously incorporated but unavailable to patients, targeting 116,000 people. This policy change addresses a gap between drug approval and patient access, reflecting a domestic health access improvement with no immediate market or geopolitical implications.